This video is offered by Stentys


Interested in a new and unique sirolimus-eluting stent system with special properties allowing it to leave an active drug presence in the vessel wall even after the polymer is fully absorbed? Want to find out how this innovative device compares to XIENCE? Join R.J. de Winter as he introduces these latest results featuring the MiStent, where the bioresorbable coating is absorbed in three months but it’s drug, delivered in microcrystalline form, remains active for up to nine months longer. Discover details about such aspects as neointimal proliferation or how non-inferiority was confirmed in the 12-month clinical outcomes here…